stockrowChampions Oncology, Inc. (CSBR) vs Fortress Biotech, Inc. (FBIO)
- Champions Oncology, Inc. CSBR 4.78 +0.42%
- Fortress Biotech, Inc. FBIO 1.83 −0.54%
Champions Oncology, Inc. and Fortress Biotech, Inc. are both Biotechnology companies. Champions Oncology, Inc. and Fortress Biotech, Inc. are of similar size ($66.3M and $61.4M). Champions Oncology, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. grew revenue faster over the last twelve months: 15.5% against 6.65%. Fortress Biotech, Inc. has the higher net margin (151.0% vs −1.87%) and the higher return on invested capital (−41.3% vs −626.2%). Across the 19 metrics below, Fortress Biotech, Inc. leads on 15 and Champions Oncology, Inc. on 4.
Valuation
Profitability
| Metric | CSBR | FBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 49.82% | 65.59% | 65.16% |
| Operating margin | (1.68%) | (42.61%) | 0.00% |
| Net margin | (1.87%) | 150.98% | 0.00% |
| Free cash flow margin | (10.08%) | 183.80% | 0.00% |
| Return on equity | (28.38%) | 84.91% | (50.12%) |
| Return on assets | (3.56%) | 43.38% | (45.60%) |
| Return on invested capital | (626.23%) | (41.34%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack